Original Research Articles
Download PDF (1.02 MB)
Journal of Structural Heart Disease, August 2016, Volume 2, Issue 4:102-107
DOI: 10.12945/j.jshd.2016.010.15
Resolution of Migraine After Transcatheter Closure of Atrial Communication
Migraine and Atrial Communication Closure
Yoichi Takaya, MD1, Teiji Akagi, MD2, Yasufumi Kijima, MD1, Koji Nakagawa, MD1, Syoichiro Kono, MD3, Kentaro Deguchi, MD3, Shunji Sano, MD4, Hiroshi Ito, MD1
1 Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
2 Cardiac Intensive Care Unit, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
3 Department of Neurology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
4 Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
Abstract
Background: Limited information is available regarding migraine in patients with atrial septal defect (ASD), and the clinical effects of transcatheter closure are controversial. We aimed to demonstrate the clinical features of migraine in patients with ASD compared with those in patients with patent foramen ovale (PFO) and evaluate the impact of transcatheter closure.
Methods: We investigated the prevalence of migraine in 68 patients with ASD and 27 patients with PFO who underwent transcatheter closure. Migraine prevalence, frequency, and severity were evaluated before and after the procedure.
Results: Twenty patients (29%) with ASD and 15 patients (56%) with PFO suffered from migraine. Characteristics such as migraine frequency and severity and incidence of aura were not different between the ASD and PFO patients. Among the 20 ASD patients, migraine disappeared in 10 (50%) and improved in 7 (35%) patients after a mean follow-up of 20 ± 8 months. Among the 15 PFO patients, migraine disappeared in 11 (73%) and improved in 3 (20%) patients.
Conclusions: Approximately 30% of patients with ASD experience migraine. The improvement in migraine after transcatheter closure is observed in the majority of those with ASD, similar to the rate of patients with PFO with improvement. These findings suggest that transcatheter closure may be beneficial for migraine in patients with atrial communication.
Cite this article as: Takaya Y, Akagi T, Kijima Y, Nakagawa K, Kono S, Deguchi K, Sano S, Ito H. Resolution of Migraine After Transcatheter Closure of Atrial Communication – Migraine and Atrial Communication Closure. Structural Heart Disease 2016;2(4):102-107. DOI: 10.12945/j.jshd.2016.010.15
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.
Original Research Articles
Journal of Structural Heart Disease, August 2016, Volume 2, Issue 4:102-107
DOI: 10.12945/j.jshd.2016.010.15
Resolution of Migraine After Transcatheter Closure of Atrial Communication
Migraine and Atrial Communication Closure
Yoichi Takaya, MD1, Teiji Akagi, MD2, Yasufumi Kijima, MD1, Koji Nakagawa, MD1, Syoichiro Kono, MD3, Kentaro Deguchi, MD3, Shunji Sano, MD4, Hiroshi Ito, MD1
1 Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
2 Cardiac Intensive Care Unit, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
3 Department of Neurology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
4 Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan
Abstract
Background: Limited information is available regarding migraine in patients with atrial septal defect (ASD), and the clinical effects of transcatheter closure are controversial. We aimed to demonstrate the clinical features of migraine in patients with ASD compared with those in patients with patent foramen ovale (PFO) and evaluate the impact of transcatheter closure.
Methods: We investigated the prevalence of migraine in 68 patients with ASD and 27 patients with PFO who underwent transcatheter closure. Migraine prevalence, frequency, and severity were evaluated before and after the procedure.
Results: Twenty patients (29%) with ASD and 15 patients (56%) with PFO suffered from migraine. Characteristics such as migraine frequency and severity and incidence of aura were not different between the ASD and PFO patients. Among the 20 ASD patients, migraine disappeared in 10 (50%) and improved in 7 (35%) patients after a mean follow-up of 20 ± 8 months. Among the 15 PFO patients, migraine disappeared in 11 (73%) and improved in 3 (20%) patients.
Conclusions: Approximately 30% of patients with ASD experience migraine. The improvement in migraine after transcatheter closure is observed in the majority of those with ASD, similar to the rate of patients with PFO with improvement. These findings suggest that transcatheter closure may be beneficial for migraine in patients with atrial communication.
PDF
Mobile-ready Flipbook
Cite this article as: Takaya Y, Akagi T, Kijima Y, Nakagawa K, Kono S, Deguchi K, Sano S, Ito H. Resolution of Migraine After Transcatheter Closure of Atrial Communication – Migraine and Atrial Communication Closure. Structural Heart Disease 2016;2(4):102-107. DOI: 10.12945/j.jshd.2016.010.15
You must be registered and logged in to leave comments.
There have been no comments posted yet
Ask a question (publicly)
Board